235 Participants Needed

OCT Device for Ear Infection

(OCTII Trial)

Recruiting at 2 trial locations
KP
RL
CE
Overseen ByChristy Erbe
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: Medical College of Wisconsin
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this project is to see if optical coherence tomography (OCT), a new technology acting as an ultrasound for the ear, facilitates accurately diagnosing acute otitis media (AOM) and otitis media with effusion (OME) in children. Clinical diagnoses made using solely otoscopy will be compared to those made with the addition of OCT.

Do I need to stop my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the OCT Device treatment for ear infections?

Research shows that OCT devices can effectively detect and differentiate middle ear effusions, which are common in ear infections. Additionally, OCT systems have been validated for use in primary care settings, demonstrating their utility in diagnosing conditions like ear infections.12345

Is the OCT Device safe for use in humans?

Research on various OCT devices, including those used for ear conditions, suggests they are generally safe for human use. Studies have demonstrated the feasibility and safety of OCT systems in different applications, such as imaging the tympanic membrane and inner ear, without reporting significant safety concerns.14567

How is the OCT Device treatment for ear infections different from other treatments?

The OCT Device for ear infections is unique because it uses optical coherence tomography to non-invasively and quantitatively assess middle ear conditions, providing detailed images and identifying bacterial biofilms, unlike traditional methods that rely on subjective visual cues. This device is portable and includes a machine learning platform for accurate diagnosis, making it a novel tool for managing ear infections.14589

Research Team

JK

Joseph Kerschner, MD

Principal Investigator

Medical College of Wisconsin

Eligibility Criteria

This trial is for children with a parent-reported ear infection or pain, or those referred for otitis media with effusion evaluation at specific clinics. Participants must speak English. Children with current ear tubes, craniofacial abnormalities, immunologic or syndromic conditions, or effusion present for less than 8 weeks are excluded.

Inclusion Criteria

Referred for evaluation of otitis media with effusion at Children's Wisconsin ENT Clinic
Speak English
My child has had ear pain or an infection, as reported at a Children's Wisconsin Urgent Care Clinic.

Exclusion Criteria

My child has a craniofacial abnormality.
Children with other syndromic conditions
Current ear tubes
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Comparative Assessment

Comparative assessment of middle ear pathology using otoscopy and OCT in pediatric patients

5 years
Multiple visits as needed for assessments

Algorithm Development

Development of image processing and machine learning algorithms for automated identification of effusions and biofilms in OCT image data

5 years

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • OCT Device(s)
Trial OverviewThe study tests if optical coherence tomography (OCT), like an ultrasound for the ear, can accurately diagnose acute otitis media and otitis media with effusion in kids. It compares clinical diagnoses using OCT alongside traditional pneumatic otoscopy to those using only pneumatic otoscopy.
Participant Groups
3Treatment groups
Experimental Treatment
Active Control
Group I: Children's Wisconsin Urgent Care ClinicsExperimental Treatment1 Intervention
Subjects will receive a standard-of-care otoscopy examination, followed by a research-only examination using an OCT device (PCT).
Group II: Children's Wisconsin (Effusion in 2 ears)Experimental Treatment1 Intervention
Subjects will receive standard-of-care ear and hearing examinations (otoscopy and audiometry/tympanometry), followed by research-only examinations using two OCT devices (UIUC OCT and PCT).
Group III: Children's Wisconsin (Effusion in 0 or 1 ear)Active Control1 Intervention
Subjects will only receive a standard-of-care otoscopy examination.

OCT Device(s) is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as OCT Device for:
  • Acute otitis media (AOM)
  • Otitis media with effusion (OME)
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as OCT Device for:
  • Middle ear effusions
  • Bacterial biofilms in the middle ear cavity

Find a Clinic Near You

Who Is Running the Clinical Trial?

Medical College of Wisconsin

Lead Sponsor

Trials
645
Recruited
1,180,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

University of Illinois at Urbana-Champaign

Collaborator

Trials
203
Recruited
40,600+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Findings from Research

The optical coherence tomography (OCT) otoscope demonstrated a high accuracy of 90.6% in detecting middle ear effusions (MEEs) among 45 pediatric patients, indicating its potential as a reliable diagnostic tool.
While the OCT otoscope was effective in detecting MEEs, it showed lower accuracy (70.8%) in differentiating between serous and nonserous MEEs, suggesting that while it is promising, further refinement may be needed for this specific application.
Otitis Media Middle Ear Effusion Identification and Characterization Using an Optical Coherence Tomography Otoscope.Preciado, D., Nolan, RM., Joshi, R., et al.[2021]
A new low-cost and portable optical coherence tomography (OCT) system has been developed, weighing only 9 kg and costing around USD $8000, making it accessible for use in primary care centers and remote areas.
This system features innovative real-time mosaicking technology that allows for the creation of detailed cross-sectional images without the need for complex lateral scanning equipment, enhancing its utility for point-of-care diagnostics.
Economical and compact briefcase spectral-domain optical coherence tomography system for primary care and point-of-care applications.Dsouza, R., Won, J., Monroy, GL., et al.[2020]
The optical coherence tomograph (OCT) is a noninvasive device that provides high-resolution images of the retina, allowing for accurate evaluation of macular and chorioretinal conditions, as well as early detection of glaucoma.
OCT examinations are minimally uncomfortable for patients and are particularly useful for assessing macular pathologies and measuring retinal nerve fiber layer thickness to evaluate glaucomatous damage.
Optical coherence tomography.Ripandelli, G., Coppรฉ, AM., Capaldo, A., et al.[2019]

References

Otitis Media Middle Ear Effusion Identification and Characterization Using an Optical Coherence Tomography Otoscope. [2021]
Economical and compact briefcase spectral-domain optical coherence tomography system for primary care and point-of-care applications. [2020]
Optical coherence tomography. [2019]
Endoscopic optical coherence tomography with wide field-of-view for the morphological and functional assessment of the human tympanic membrane. [2020]
In vivo microstructural investigation of the human tympanic membrane by endoscopic polarization-sensitive optical coherence tomography. [2023]
Optical coherence tomography imaging of the inner ear: a feasibility study with implications for cochlear implantation. [2017]
Feasibility and Safety of a Coaxial Dual-Wavelength Optical Coherence Tomography Apparatus. [2021]
Handheld Briefcase Optical Coherence Tomography with Real-Time Machine Learning Classifier for Middle Ear Infections. [2021]
Optical coherence tomography in the 2020s-outside the eye clinic. [2021]